Current aspects and future trends of computer-aided rescaffolding

di Baringhaus, Karl-Heinz, Hessler, Gerhard, Klabunde, Thomas
Pubblicazione 2010

DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data

di Pacini, Clare, Iorio, Francesco, Gonçalves, Emanuel, Iskar, Murat, Klabunde, Thomas, Bork, Peer, Saez-Rodriguez, Julio
Pubblicazione 2013

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

di Schiavon, Michele, Visentin, Roberto, Giegerich, Clemens, Sieber, Jochen, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Pubblicato in Diabetes Technol Ther (2020)

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation

di Peterson, Scott A., Klabunde, Thomas, Lashuel, Hilal A., Purkey, Hans, Sacchettini, James C., Kelly, Jeffrey W.
Pubblicazione 1998

Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion

di Sacco, Francesca, Humphrey, Sean J., Cox, Jürgen, Mischnik, Marcel, Schulte, Anke, Klabunde, Thomas, Schäfer, Matthias, Mann, Matthias
Pubblicato in Nat Commun (2016)

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

di Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Pubblicato in Diabetes Technol Ther (2016)

Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs

di Oikonomakos, Nikos G., Kosmopoulou, Magda N., Chrysina, Evangelia D., Leonidas, Demetres D., Kostas, Ioannis D., Wendt, K. Ulrich, Klabunde, Thomas, Defossa, Elisabeth
Pubblicazione 2005